Journal profile · Pharmacology & Pharmacy

Drug News & Perspectives

ISSN 0214-0934 · SPAIN · Monthly · Founded 1988

Drug News & Perspectives: subscription journal; review over 12 weeks (community reports); community-reported acceptance: moderate; 0 articles in 2025.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartile—No CiteScore rank
Review timeover 12 weeksCommunity average
APC—No source gives fee information
AcceptanceModerateCommunity average
Articles per year02025 · OpenAlex count

Scope

Aims, scope and focus

By OpenAlex counts of its recent articles, Drug News & Perspectives's largest topics are Alzheimer's disease research and treatments, Pharmaceutical Economics and Policy and Neuroscience and Neuropharmacology Research, together about 23% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): Pharmacology & Pharmacy

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Alzheimer's disease research and treatmentsMedicine8.1%
  2. Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance7.7%
  3. Neuroscience and Neuropharmacology ResearchNeuroscience7.2%
  4. Pharmaceutical industry and healthcarePharmacology, Toxicology and Pharmaceutics6.3%
  5. Neuropeptides and Animal PhysiologyNeuroscience5.5%
  6. Immunotherapy and Immune ResponsesImmunology and Microbiology4.8%
  7. Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology4.5%
  8. Regulation of Appetite and ObesityNeuroscience3.9%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

Indexed in: no record yet.

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

h-index
59OpenAlex ·
i10-index
378OpenAlex ·
2-year mean citedness
0OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 649 in total · the current year is incomplete

YearArticlesOpen accessCitations
202600190
202500337
202400378
202300410
202200481
202100512

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
over 12 weeksLetPub ·
Average acceptance (community reports)
ModerateLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Subscription journalLetPub

A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Country or region
SPAIN
Frequency
Monthly
Founded
1988
ISSN
0214-0934
Official links

FAQ

Frequently asked questions about Drug News & Perspectives

How long does peer review take at Drug News & Perspectives?

Authors report an average review time of over 12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Is Drug News & Perspectives open access, and what is the APC?

Drug News & Perspectives is a subscription journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .